Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. EuroEyes International Eye Clinic's annualizedNet Income for the quarter that ended in Dec. 2025 was HK$32.1 Mil.
EuroEyes International Eye Clinic's average Total Assets over the quarter that ended in Dec. 2025 was HK$1,882.0 Mil. Therefore, EuroEyes International Eye Clinic's annualized ROA % for the quarter that ended in Dec. 2025 was 1.71%.
HKSE:01846'
s ROA % Range Over the Past 10 Years
Min: -0.38 Med: 5.65 Max: 20.67
Current: 3.05
During the past 10 years, EuroEyes International Eye Clinic's highest ROA % was 20.67%. The lowest was -0.38%. And the median was 5.65%.
HKSE:01846's ROA % is ranked better than 55.8% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 1.81
vs HKSE:01846: 3.05
EuroEyes International Eye Clinic (HKSE:01846) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
EuroEyes International Eye Clinic ROA % Related Terms
EuroEyes International Eye Clinic ROA % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, EuroEyes International Eye Clinic's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EuroEyes International Eye Clinic ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EuroEyes International Eye Clinic's ROA % distribution charts can be found below:
* The bar in red indicates where EuroEyes International Eye Clinic's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
EuroEyes International Eye Clinic (HKSE:01846) has a ROA % of 1.71% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on EuroEyes International Eye Clinic and its competitors. This is 70% below median its historical median of 5.65. According to the industry distribution chart, EuroEyes International Eye Clinic ranks #301 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 44.2%.
Is EuroEyes International Eye Clinic's ROA % too high?
EuroEyes International Eye Clinic's current ROA % of 1.71% is 70% below median its 10-year median of 5.65. The Healthcare Providers & Services industry median ROA % is 1.81. EuroEyes International Eye Clinic's value of 1.71% is 5.5% below this industry median. Based on the distribution chart, EuroEyes International Eye Clinic ranks #301 out of 681 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, EuroEyes International Eye Clinic has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EuroEyes International Eye Clinic's ROA % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, EuroEyes International Eye Clinic ranks #301 out of 681 companies for ROA %. This puts EuroEyes International Eye Clinic in the upper half of its industry. The industry median ROA % is 1.81. EuroEyes International Eye Clinic's value of 1.71% is 5.5% below this benchmark. While the company's 10-year median is 5.65 vs. the industry median of 1.81, EuroEyes International Eye Clinic has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.81, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EuroEyes International Eye Clinic's current ROA % of 1.71% is 5.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on EuroEyes International Eye Clinic and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EuroEyes International Eye Clinic's current ROA % is 1.71%, which is 70% below median its own 10-year median of 5.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EuroEyes International Eye Clinic stock overvalued right now?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic (HKSE:01846) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$5.54, compared to a current price of HK$2.40 — trading 56.7% below its estimated fair value. The current ROA % is 1.71%, which is 70% below median its 10-year median of 5.65 and 5.5% below the Healthcare Providers & Services industry median of 1.81. EuroEyes International Eye Clinic's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For EuroEyes International Eye Clinic (HKSE:01846), the current ROA % is 1.71% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EuroEyes International Eye Clinic (HKSE:01846) Overvalued in 2026?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic stock appears to be undervalued.
The current stock price of HK$2.40 is trading 56.7% below its estimated GF Value™ of HK$5.54.
GuruFocus considers EuroEyes International Eye Clinic to be Significantly Undervalued.
Key valuation signals for HKSE:01846:
ROA %: 1.71% (70% below median its 10-year median of 5.65)
GF Value™: HK$5.54 vs. price of HK$2.40 (56.7% below fair value)
Industry Position: 5.5% below the Healthcare Providers & Services median (#301 of 681)
No single metric tells the full story. See the HKSE:01846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EuroEyes International Eye Clinic Business Description
EuroEyes International Eye Clinic Ltd is principally engaged in the provision of vision correction services in Germany, Denmark, the UK, the PRC including Hong Kong, and Switzerland. The Group is a high-end vision correction service provider in Germany, PRC, the UK, Denmark, and Switzerland. Its vision correction services include refractive laser surgery, phakic lens surgery (ICL), lens exchange surgery, and others including PRK/LASEK and ICRS implantation. Its revenue categories include provision of vision correction services generate maximum revenue, training services, sales of pharmaceutical products and others. The Group's five reportable segments are Germany generate maximum revenue, Denmark, UK, Chinese Mainland, and Switzerland.
79GF Score
Get the complete analysis for HKSE:01846
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01846 has been successfully added to your 
